TGF-β-mediated EMT decreases Dlg5 expression. by Takuhito Sezaki (169150)

“…TGF-β treatment induced EMT and decreased Dlg5 expression. The results are representative of at least three independent experiments.…”

5-AZA decreases DNA methylation levels in neonatal hearts. by Maresha S. Gay (693467)

ApoE3 decreases Rho activity and F-actin stress fibers in human VSMCs. by Bernadette Y. Hsu (753458)

YTX treatment decreases tumour development in the B16F10 melanoma mouse model. by Araceli Tobío (3545306)

Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation. by Kyle C. Kloepping (9928265)

“…At the 25 min mark, 1.0 μM 12-TPP was added to treatment A375 cells followed by the sequential addition of 2.5 μM oligomycin at the 60 min mark, 0.3 μM oligomycin at the 90 min mark, and 5.0 μM rotenone/antimycin A at the 120 min mark. …”

Excision of HIF1α decreases viral reactivation from latency in infected splenocytes in vivo. by Darlah M. López-Rodríguez (8098544)

PLD1 inhibition decreases the c-Myc-dependent dNTP biosynthetic transcriptional program. by Harry E. Taylor (596259)

S-glutathionylation catalyst diamide also decreases ROS release from permeabilized skeletal muscle mitochondria. by Robert M. Gill (4854028)

“…The final concentration of pyruvate, 2-oxoglutarate, succinate, or palmitoyl-carnitine was 50 μM. n = 4, mean±SEM. (B) The decrease in mitochondrial ROS release correlates with an increase in overall protein S-glutathionylation. …”

Ionic currents of aglycoform decreased more readily during repetitive depolarization pulses than glycoform. by M. K. Hall (352643)

Methylation levels of the <i>Ucp1</i> promoter decreased following genistein (GEN) treatment. by Noriko Sato (201880)

Loss of ALS2 results in decreased levels of the lysosome-dependent degradation of LC3 in fibroblasts. by Shinji Hadano (251529)

“…Fibroblasts derived from either wild-type (<i>Als2</i>^+/+) or <i>Als2</i>^−/− mice were incubated in a starvation medium with or without 0.5 µM chloroquine (CQ) for 6 hr. …”

Decreased reactive gliosis following ES delivered 5d post-demyelination. by Nikki A. McLean (643606)

“…Contralateral intact control nerves displayed only minimal GFAP IF (A). However 5d post-lysophosphatidyl choline (LPC)/FG injection there was a marked increase in GFAP IF (B). …”

Parkin decreases total and cell surface expressed Ca_V2.2 channels. by Lizbeth Grimaldo (4476871)

Decreased capillary density and cardiac fibrosis in <i>Nkx2.5-Cre/Foxm1^fl/fl</i> heart. by Craig Bolte (299486)

“…Scale bars represent 100 µm in A–F and 50 µm in G–H.</p>…”

SDG decreases iron-induced apoptosis in H9c2 cells. by Stephanie Puukila (568109)

High concentrations of UA lead to decrease of TRACP 5b levels. by Zhi-Qi Wu (847506)

SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT). by Eduardo Molina-Jijón (4020464)

“…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”

Cell growth and viability decrease confirmed by growth inhibition in HepG3. by Arlet Hernandez (12289155)

50 WT 5′ and 3′ terminal nts of the S1 gene are sufficient to package a non-MRV gene into infectious virions. by Debarpan Dhar (724473)

Whole brain volume change over 5 years using the SIENA pipeline. by Renxin Chu (5169857)